US loss of exclusivity · Immunology
Xolair
Roche / Novartis
2026
US biosimilars on sale
2025
Today: 2026
2037
2025 worldwide sales
≈$5.4B
Date basis
Biosimilars launched
US biosimilars
Copies on the US market
Medicare price
Pending, from 2028
Pharma Patent Cliff
by readouts.io
Data checked 8 October 2026 ·
Full Xolair timeline →